Drug regulators in driving seat in planned ICH reforms
This article was originally published in Scrip
Executive Summary
Wide-ranging governance reforms are being considered at the International Conference on Harmonisation to redefine the respective roles of regulators and industry in developing harmonised guidelines for the pharmaceutical sector. Global expansion of the initiative is likely under the reform, with the possibility of Brazil, Russia, China, India and other countries progressively joining the US, the EU and Japan as members.